You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 豐原藥業(000153.SZ)漲停 疫情致撲熱息痛原料藥需求暴增
格隆匯 05-08 11:33
格隆匯5月8日丨豐原藥業(000153.SZ)放量漲停,現報8.13元,暫成交放大至2.05億元,最新總市值25.38億元。據百川盈孚數據,全球最大的撲熱息痛原料藥生產企業山東魯安藥業4月16日報價43元/公斤,4月29日的報價則高達100元/公司,不到半個月漲幅超過130%。因突然爆發的新冠肺炎疫情迅速蔓延全球,推動歐美各國對撲熱息痛片的需求數量暴增。豐原藥業旗下利康藥業公司目前撲熱息痛產能已達2萬噸,成為國內第二大撲痛原料藥生產商。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account